Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease.
about
Attentional set-shifting deficit in Parkinson's disease is associated with prefrontal dysfunction: an FDG-PET studyVisual dysfunction in Parkinson's diseaseStructural Neuroimaging Markers of Cognitive Decline in Parkinson's DiseaseValue and Efficacy of Transcranial Direct Current Stimulation in the Cognitive Rehabilitation: A Critical Review Since 2000Cognitive training in Parkinson disease: A systematic review and meta-analysisNeuroimaging studies of striatum in cognition part II: Parkinson's diseaseAdult hippocampal neurogenesis in Parkinson's disease: impact on neuronal survival and plasticityLevodopa-induced plasticity: a double-edged sword in Parkinson's disease?Cognitive interventions in Alzheimer's and Parkinson's diseases: emerging mechanisms and role of imagingToxin-Induced Experimental Models of Learning and Memory ImpairmentAssessment of cognitive safety in clinical drug developmentNucleus basalis of Meynert revisited: anatomy, history and differential involvement in Alzheimer's and Parkinson's diseaseParkinson's Disease and Cognitive ImpairmentParkinson Disease and Dementia.Diagnostic Accuracy and Confidence in the Clinical Detection of Cognitive Impairment in Early-Stage Parkinson Disease.Noradrenergic Modulation of Cognition in Health and Disease.Not all sounds sound the same: Parkinson's disease affects differently emotion processing in music and in speech prosody.Impairment of brainstem implicit learning paradigms differentiates multiple system atrophy (MSA) from idiopathic Parkinson syndromeGray matter atrophy in Parkinson's disease with dementia: evidence from meta-analysis of voxel-based morphometry studies.Dementia and neuroimaging.New MRI Biomarkers Advance the Characterization of Parkinson Disease.Default mode network differences between rigidity- and tremor-predominant Parkinson's diseasePropagation of pathology through brain networks in neurodegenerative diseases: from molecules to clinical phenotypes.Resting-state functional brain networks in Parkinson's disease.Orthostatic hypotension and cognitive impairment in Parkinson's disease: Causation or association?Dopamine treatment and cognitive functioning in individuals with Parkinson's disease: the "cognitive flexibility" hypothesis seems to work.Potential biomarkers relating pathological proteins, neuroinflammatory factors and free radicals in PD patients with cognitive impairment: a cross-sectional studyImproving Dual-Task Walking Paradigms to Detect Prodromal Parkinson's and Alzheimer's Diseases.The neurobiological basis of cognitive impairment in Parkinson's disease.Comparing cerebral perfusion in Alzheimer's disease and Parkinson's disease dementia: an ASL-MRI study.Targeting impulsivity in Parkinson's disease using atomoxetineDesigner receptors: therapeutic adjuncts to cell replacement therapy in Parkinson's disease.Associations between cognitive impairment and motor dysfunction in Parkinson's diseaseVariants in SNCA Gene Are Associated with Parkinson's Disease Risk and Cognitive Symptoms in a Brazilian Sample.Initial cognitive decline is associated with cortical thinning in early Parkinson disease.Visual short-term memory deficits associated with GBA mutation and Parkinson's disease.Longitudinal changes in task-evoked brain responses in Parkinson's disease patients with and without mild cognitive impairment.Alzheimer's disease pattern of brain atrophy predicts cognitive decline in Parkinson's diseaseSimulating category learning and set shifting deficits in patients weight-restored from anorexia nervosaGenetic impact on cognition and brain function in newly diagnosed Parkinson's disease: ICICLE-PD study
P2860
Q21134536-A2B84608-F2FE-4E07-838E-B05BCD324028Q26740467-4BF2C53D-EAAB-4890-9B2A-228824036CE6Q26748709-35E61990-8480-4FCD-A778-DFF0B084AC43Q26752735-009BB538-B8AC-47EF-8C84-F8822FBC3339Q26777668-65AAFC0C-6FF1-41B4-9E16-207209D58BEFQ26779306-A994517C-ED9D-4BA8-867D-DEFFD7E9DF24Q26862840-8FB125D9-932D-4E5A-BC6E-64E399E35E59Q27002626-A2046BD6-C9DC-4983-AA96-D0EDE75B7249Q28071285-5F21CCAC-F09A-47B4-A360-FE84211F272EQ28075913-49C51999-154A-4EEE-BECA-65FA84581D32Q28084637-213216CE-DF70-4126-81F6-F95EBD1FCE7DQ28085513-775912D9-8C03-4E67-B1D4-4AAD3197FCF2Q30239814-6744E8D8-53C3-470A-80A3-121FE4A95B3EQ30248574-56DCE5A4-ECD3-4CB3-A5CF-B274D3AB8B71Q30252794-1CBA21B1-0B44-4CFD-AE88-4E3D68E6F8F7Q30354689-479933E3-75A0-4598-8337-266A255D3B2CQ30428075-D43794F0-63F4-47CD-8A02-C6E57C6664B8Q30544858-2FC9DDFC-1FBE-4596-9C61-A24064933A6FQ30578597-DC0A9ADB-7CB4-4113-8225-14C33E80BA60Q30581757-49AC6089-2484-457C-A862-5CC77C154DD9Q30835312-C4BDEC54-4F8A-47FF-BBDC-840D3A022191Q30843485-2698EB4A-0EF0-4542-9E33-3012CD3683C6Q30962548-23CE06D4-9DD0-4E33-86F0-788442F63A91Q30983855-ACC98A9D-EEBE-4F4A-9265-6D0CF19D5A0CQ31080551-EBAB221D-4288-4DC0-BD5D-3CEFCE7193E5Q33552399-9D2B235D-EE4B-469C-ABC1-4D7F297276C1Q33672820-380AC43C-5E6F-44C6-AFD9-FDF534EBD063Q33710775-9804764A-6428-4651-BDD4-1FB3BEE217A0Q33724698-DCF79944-D6FB-4099-A99F-86DD45DF6B9BQ33729235-B558B3CF-AA69-4457-AC8A-BDE3253B5944Q33784038-86F54A2B-3A04-49F7-A703-F1811A534D58Q33808289-06A731D1-9C0E-40C6-A1F6-692F4E59DC21Q33810161-F441A6DD-0AB8-4DDF-BA52-3F1BD8A0E259Q33813336-C60EB4EC-F720-4BA2-BFB7-195F728BB637Q33927210-08060F13-EEAC-4806-ADC3-F970D50025DEQ33937498-7A2EF9A4-6B13-43F2-B53B-647A257425D5Q33965475-9DAEA3FF-C5AE-4161-975E-C76F5F14476BQ34080479-DAB3BB06-A0D4-41FF-A5ED-03DB12437BBAQ34084534-5C4FC9F0-0322-4677-A478-63E718C9D326Q34174901-2E34E793-FE8B-4194-BE06-3D4D586A9E8B
P2860
Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 27 September 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Neuropsychological and clinica ...... ents with Parkinson's disease.
@en
Neuropsychological and clinica ...... ents with Parkinson's disease.
@nl
type
label
Neuropsychological and clinica ...... ents with Parkinson's disease.
@en
Neuropsychological and clinica ...... ents with Parkinson's disease.
@nl
prefLabel
Neuropsychological and clinica ...... ents with Parkinson's disease.
@en
Neuropsychological and clinica ...... ents with Parkinson's disease.
@nl
P921
P1433
P1476
Neuropsychological and clinica ...... ents with Parkinson's disease.
@en
P2093
Angie A Kehagia
P304
P356
10.1016/S1474-4422(10)70212-X
P577
2010-09-27T00:00:00Z